1,25-Dihydroxyvitamin D fluctuations in cardiac surgery are related to age and clinical outcome

Critical Care Medicine

Volumn 40, Issue 7, 2012, Pages 2073-2081

  Börgermann, Jochen ^a   Lazouski, Kanstantsin ^a   Kuhn, Joachim ^a   Dreier, Jens ^a   Schmidt, Michael ^a   Gilis Januszewski, Thomas ^a   Knabbe, Cornelius ^a   Gummert, Jan F ^a   Zittermann, Armin ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

1,25 dihydroxyvitamin D; age; cardiac surgery; clinical outcome; kidney function; vitamin D

Indexed keywords

C REACTIVE PROTEIN; CALCITRIOL; HLA DR ANTIGEN; INTERLEUKIN 6; INTERLEUKIN 8; PARATHYROID HORMONE;

ADULT; AGE; AGED; ARTICLE; BLOOD ANALYSIS; CALCIUM METABOLISM; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); FEMALE; GERMANY; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HEART OUTPUT; HEART SURGERY; HORMONE METABOLISM; HUMAN; IMMUNE STATUS; INFECTION; MAJOR CLINICAL STUDY; MALE; PHOSPHATE METABOLISM; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; STROKE; TREATMENT OUTCOME; VITAMIN METABOLISM;

AGE FACTORS; AGED; C-REACTIVE PROTEIN; CALCIUM; CARDIAC OUTPUT, LOW; CD4-CD8 RATIO; CORONARY ARTERY BYPASS; FEMALE; GLOMERULAR FILTRATION RATE; HEART VALVE PROSTHESIS IMPLANTATION; HLA-DR ANTIGENS; HUMANS; INTENSIVE CARE UNITS; INTERLEUKIN-6; INTERLEUKIN-8; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; MONOCYTES; MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT (HEALTH CARE); PARATHYROID HORMONE; PHOSPHATES; PROSPECTIVE STUDIES; SURGICAL WOUND INFECTION; VITAMIN D;

EID: 84862772864     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31824e8c42     Document Type: Article

References (55)

1. Hirose H, Amano A, Yoshida S, et al: Coronary artery bypass grafting in the elderly. Chest 2000; 117:1262-1270 (Pubitemid 30321577)
2. Alexander KP, Anstrom KJ, Muhlbaier LH, et al: Outcomes of cardiac surgery in patients or = 80 years: Results from the National Cardiovascular Network. J Am Coll Cardiol 2000; 35:731-738 (Pubitemid 30167031)
3. Mooradian AD, Morley JE, Korenman SG: Endocrinology in aging. Dis Mon 1988; 34:393-461
4. Pendergast DR, Fisher NM, Calkins E: Cardiovascular, neuromuscular, and metabolic alterations with age leading to frailty. J Gerontol 1993; 48 Spec No:61-67 (Pubitemid 23307867)
5. DeVeale B, Brummel T, Seroude L: Immunity and aging: The enemy within? Aging Cell 2004; 3:195-208 (Pubitemid 40246684)
6. Dobnig H, Pilz S, Scharnagl H, et al: Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 2008; 168:1340-1349 (Pubitemid 351930842)
7. Wang TJ, Pencina MJ, Booth SL, et al: Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008; 117:503-511
8. Giovannucci E, Liu Y, Hollis BW, et al: 25-hydroxyvitamin D and risk of myocardial infarction in men: A prospective study. Arch Intern Med 2008; 168:1174-1180 (Pubitemid 351831400)
9. Zittermann A, Schleithoff SS, Frisch S, et al: Circulating calcitriol concentrations and total mortality. Clin Chem 2009; 55:1163-1170
10. Zittermann A, Schleithoff SS, Götting C, et al: Calcitriol deficiency and 1-year mortality in cardiac transplant recipients. Transplantation 2009; 87:118-124
11. Equils O, Naiki Y, Shapiro AM, et al: 1,25-Dihydroxyvitamin D inhibits lipopolysaccharide-induced immune activation in human endothelial cells. Clin Exp Immunol 2006; 143:58-64
12. Müller K, Haahr PM, Diamant M, et al: 1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level. Cytokine 1992; 4:506-512
13. Van Etten E, Mathieu C: Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts. J Steroid Biochem Mol Biol 2005; 97:93-101
14. Wood RJ, Fleet JC, Cashman K, et al: Intestinal calcium absorption in the aged rat: Evidence of intestinal resistance to 1,25(OH)2 vitamin D. Endocrinology 1998; 139:3843-3848 (Pubitemid 28512266)
15. Dubbelman R, Jonxis JH, Muskiet FA, et al: Age-dependent vitamin D status and vertebral condition of white women living in Curaçao (The Netherlands Antilles) as compared with their counterparts in The Netherlands. Am J Clin Nutr 1993; 58:106-109 (Pubitemid 23193243)
16. Need AG, O'Loughlin PD, Morris HA, et al: The effects of age and other variables on serum parathyroid hormone in postmenopausal women attending an osteoporosis center. J Clin Endocrinol Metab 2004; 89:1646-1649 (Pubitemid 38507915)
17. Bischoff-Ferrari HA, Borchers M, Gudat F, et al: Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res 2004; 19:265-269 (Pubitemid 38116740)
18. Guillemant J, Oberlin F, Bourgeois P, et al: Age-related effect of a single oral dose of calcium on parathyroid function: Relationship with vitamin D status. Am J Clin Nutr 1994; 60:403-407 (Pubitemid 24278744)
19. Abbott: ARCHITECT Cystatin C product information. http://www. abbottdiagnostics.at/images/content/pdfs/CystatinCInfobroschuere.pdf. Accessed September, 13, 2011
20. Roodnat JI, Mulder PG, Tielens ET, et al: The Cox proportional hazards analysis in words: examples in the renal transplantation field. Transplantation 2004; 77:483-488 (Pubitemid 38282797)
21. D'Agostino RB Jr: Propensity scores in cardiovascular research. Circulation 2007; 115:2340-2343 (Pubitemid 46685902)
22. Krishnan A, Ochola J, Mundy J, et al: Acute fluid shifts influence the assessment of serum vitamin D status in critically ill patients. Crit Care 2010; 14:R216
23. Zittermann A, Sabatschus O, Jantzen S, et al: Exercise-trained young men have higher calcium absorption rates and plasma calcitriol levels compared with age-matched sedentary controls. Calcif Tissue Int 2000; 67:215-219 (Pubitemid 30643858)
24. Brickman AS, Coburn JW, Kurokawa K, et al: Actions of 1,25-dihydroxycholecalciferol in patients with hypophosphatemic, vitamin-D-resistant rickets. N Engl J Med 1973; 289:495-498
25. Jüppner H: Phosphate and FGF-23. Kidney Int Suppl 2011; 79:S24-S27
26. Autier P, Gandini S: Vitamin D supplementation and total mortality: A meta-analysis of randomized controlled trials. Arch Intern Med 2007; 167:1730-1737 (Pubitemid 47403059)
27. Grandi NC, Breitling LP, Brenner H: Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies. Prev Med 2010; 51:228-233
28. Urashima M, Segawa T, Okazaki M, et al: Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 2010; 91:1255-1260
29. Laaksi I, Ruohola JP, Mattila V, et al: Vitamin D supplementation for the prevention of acute respiratory tract infection: A randomized, double-blinded trial among young Finnish men. J Infect Dis 2010; 202:809-814
30. Pilz S, Tomaschitz A, Drechsler C, et al: Vitamin D deficiency and myocardial diseases. Mol Nutr Food Res 2010; 54:1103-1113
31. Chen S, Law CS, Grigsby CL, et al: Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy. Circulation 2011; 124:1838-1847
32. Börgermann J, Flohé S, Scheubel RJ, et al: Regulation of cytokine synthesis in cardiac surgery: Role of extracorporeal circuit and humoral mediators in vivo and in vitro. Inflamm Res 2007; 56:126-132 (Pubitemid 46570796)
33. Laffey JG, Boylan JF, Cheng DC: The systemic inflammatory response to cardiac surgery: Implications for the anesthesiologist. Anesthesiology 2002; 97:215-252 (Pubitemid 34733943)
34. Markewitz A, Lante W, Franke A, et al: Alterations of cell-mediated immunity following cardiac operations: Clinical implications and open questions. Shock 2001; 16 (Suppl 1):10-15
35. Schuett H, Luchtefeld M, Grothusen C, et al: How much is too much? Interleukin-6 and its signalling in atherosclerosis. Thromb Haemost 2009; 102:215-222
36. Zehnder D, Quinkler M, Eardley KS, et al: Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation. Kidney Int 2008; 74:1343-1353
37. Franke A, Lante W, Zoeller LG, et al: Delayed recovery of human leukocyte antigen-DR expression after cardiac surgery with early non-lethal postoperative complications: only an epiphenomenon? Interact Cardiovasc Thorac Surg 2008; 7:207-211 (Pubitemid 351497544)
38. Cheron A, Floccard B, Allaouchiche B, et al: Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma. Crit Care 2010; 14:R208
39. Rigby WF, Waugh M, Graziano RF: Regulation of human monocyte HLA-DR and CD4 antigen expression, and antigen presentation by 1,25-dihydroxyvitamin D3. Blood 1990; 76:189-197 (Pubitemid 20220810)
40. Dusso A, Arcidiacono MV, Yang J, et al: Vitamin D inhibition of TACE and prevention of renal osteodystrophy and cardiovascular mortality. J Steroid Biochem Mol Biol 2010; 121:193-198
41. Agarwal R, Acharya M, Tian J, et al: Antiproteinuric effect of oral paricalcitol in chronic kidney disease. Kidney Int 2005; 68:2823-2828 (Pubitemid 43251029)
42. Alborzi P, Patel NA, Peterson C, et al: Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: A randomized double-blind pilot trial. Hypertension 2008; 52:249-255
43. Kim MJ, Frankel AH, Donaldson M, et al: Oral cholecalciferol decreases albuminuria and urinary TGF-ß1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition. Kidney Int 2011; 80:851-860
44. Helvig CF, Cuerrier D, Hosfield CM, et al: Dysregulation of renal vitamin D metabolism in the uremic rat. Kidney Int 2010; 78:463-472
45. Melamed ML, Astor B, Michos ED, et al: 25-hydroxyvitamin D levels, race, and the progression of kidney disease. J Am Soc Nephrol 2009; 20:2631-2639
46. Pilz S, Iodice S, Zittermann A, et al: Vitamin D status and mortality risk in CKD: A meta-analysis of prospective studies. Am J Kidney Dis 2011; 58:374-382
47. Pilz S, Tomaschitz A, Friedl C, et al: Vitamin D status and mortality in chronic kidney disease. Nephrol Dial Transplant 2011; 26:3603-3609
48. Vieth R, Fraser D, Kooh SW: Low dietary calcium reduces 25-hydroxycholecalciferol in plasma of rats. J Nutr 1987; 117:914-918 (Pubitemid 17093572)
49. Tuohimaa P, Tenkanen L, Ahonen M, et al: Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case-control study in the Nordic countries. Int J Cancer 2004; 108:104-108 (Pubitemid 37444451)
50. Melamed ML, Michos ED, Post W, et al: 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008; 168:1629-1637
51. Michaëlsson K, Baron JA, Snellman G, et al: Plasma vitamin D and mortality in older men: A community-based prospective cohort study. Am J Clin Nutr 2010; 92:841-848
52. IOM (Institute of Medicine): Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC, The National Academies Press, 2011
53. Amrein K, Sourij H, Wagner G, et al: Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: A randomized, double-blind, placebo-controlled pilot study. Crit Care 2011;15:R104
54. Jean G, Terrat JC, Vanel T, et al: Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: Evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment. Nephron Clin Pract 2008; 110:c58-c65
55. Jean G, Souberbielle JC, Chazot C: Monthly cholecalciferol administration in haemodialysis patients: A simple and efficient strategy for vitamin D supplementation. Nephrol Dial Transplant 2009; 24:3799-3805